PRMT1 significantly contributes to chemoresistance in TNBC by altering the methylation of key molecules like epidermal growth factor receptor (EGFR) and phosphoglycerate dehydrogenase (PHGDH), which strengthens tumor resilience [32,33]. The gene discussed is EGFR; the disease is neoplasm.